# An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC

> **NCT05932836** · — · ACTIVE_NOT_RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 165 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** No interventions.

## Key facts

- **NCT ID:** NCT05932836
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-09-30
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05932836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05932836, "An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05932836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*